Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

PHSYX vs GGHCX overlap: 57% of top holdings shared

Bottom line

How much do PHSYX and GGHCX overlap?

57% of their top holdings overlap by weight. 11 securities appear in both funds' top 25, making up 56.2% of PHSYX's assets and 45.5% of GGHCX's. They share a meaningful core but differ in the rest of the portfolio.

Updated Nov 22, 2026

Overlap at a glance

PHSYXGGHCX
Weight overlap (top 25)57%
Shared holdings11
Weight in shared holdings56.2%45.5%
Total positions11582
Expense ratio0.79%1.07%
Holdings as ofMay 31, 2026Jul 31, 2026

Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)

Holdings PHSYX and GGHCX have in common

Holding% of PHSYX% of GGHCXOverlap
Eli Lilly & Co.13.15%10.59%10.59%
Johnson & Johnson8.46%6.76%6.76%
UnitedHealth Group, Inc.6.93%6.17%6.17%
AbbVie, Inc.6.05%4.03%4.03%
Merck & Co., Inc.4.88%4.59%4.59%
Thermo Fisher Scientific, Inc.4.50%1.55%1.55%
Edwards Lifesciences Corp.2.80%1.56%1.56%
CVS Health Corp.2.74%2.52%2.52%
Gilead Sciences, Inc.2.63%3.63%2.63%
Cardinal Health, Inc.2.12%2.10%2.10%
Vertex Pharmaceuticals, Inc.1.97%2.01%1.97%

Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in PHSYX

  1. Novartis AG — 5.13%
  2. AstraZeneca plc — 4.67%
  3. Intuitive Surgical, Inc. — 4.04%
  4. Sanofi SA — 3.23%
  5. Roche Holding AG — 2.79%
  6. McKesson Corp. — 2.14%
  7. Novo Nordisk A/S — 1.90%
  8. Boston Scientific Corp. — 1.80%
  9. Bristol-Myers Squibb Co. — 1.75%
  10. Dexcom, Inc. — 1.64%
  11. Hoya Corp. — 1.52%
  12. Putnam Short Term Investment Fund — 1.35%
  13. HCA Healthcare, Inc. — 1.18%
  14. Amgen, Inc. — 1.11%

Only in GGHCX

  1. Invesco Private Prime Fund — 4.67%
  2. argenx SE — 3.24%
  3. Welltower Inc. — 2.34%
  4. BrightSpring Health Services, Inc. — 2.20%
  5. Royalty Pharma PLC — 2.13%
  6. Guardant Health, Inc. — 2.04%
  7. Invesco Private Government Fund — 1.80%
  8. Axsome Therapeutics, Inc. — 1.58%
  9. Invesco Treasury Portfolio — 1.56%
  10. BridgeBio Pharma, Inc. — 1.43%
  11. Waters Corp. — 1.41%
  12. IQVIA Holdings Inc. — 1.32%
  13. U C B S.a. — 1.24%
  14. Ligand Pharmaceuticals Inc. — 1.18%

Asset mix

Asset typePHSYXGGHCX
Stocks98.2%97.5%
Cash & short-term funds0.6%8.8%
Other1.4%—

Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)

Country mix

CountryPHSYXGGHCX
US76.2%93.5%
CH7.9%2.7%
GB6.4%3.1%
NL1.2%3.4%
FR3.2%—
DK2.4%1.1%
JP2.4%—
BE—1.2%

Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)

Check another pair

FAQ

How much do PHSYX and GGHCX overlap?
About 57% by weight. 11 securities appear in both funds' top 25 holdings; they make up 56.2% of PHSYX's assets and 45.5% of GGHCX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do PHSYX and GGHCX have in common?
The largest shared holdings are Eli Lilly & Co., Johnson & Johnson, UnitedHealth Group, Inc., Merck & Co., Inc., AbbVie, Inc..
Should I own both PHSYX and GGHCX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, PHSYX or GGHCX?
PHSYX is broader, with 115 positions versus 82 for GGHCX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.